TRDA
Price
$13.50
Change
+$0.34 (+2.58%)
Updated
May 6, 6:59 PM EST
2 days until earnings call
TRVI
Price
$2.94
Change
-$0.08 (-2.65%)
Updated
May 6, 6:59 PM EST
Earnings call today
Ad is loading...

Compare predictions TRDA vs TRVI

Header iconTRDA vs TRVI Comparison
Open Charts TRDA vs TRVIBanner chart's image
Entrada Therapeutics
Price$13.50
Change+$0.34 (+2.58%)
Volume$12.64K
CapitalizationN/A
Trevi Therapeutics
Price$2.94
Change-$0.08 (-2.65%)
Volume$27.88K
CapitalizationN/A
View a ticker or compare two or three
TRDA vs TRVI Comparison Chart

Loading...

TRDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRVIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
TRDA vs. TRVI commentary
May 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRDA is a Buy and TRVI is a Hold.

COMPARISON
Comparison
May 07, 2024
Stock price -- (TRDA: $13.16 vs. TRVI: $3.02)
Brand notoriety: TRDA and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRDA: 49% vs. TRVI: 10%
Market capitalization -- TRDA: $443.2M vs. TRVI: $212.71M
TRDA [@Biotechnology] is valued at $443.2M. TRVI’s [@Biotechnology] market capitalization is $212.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $545.88B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRDA’s FA Score shows that 1 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • TRDA’s FA Score: 1 green, 4 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRDA’s TA Score shows that 5 TA indicator(s) are bullish while TRVI’s TA Score has 5 bullish TA indicator(s).

  • TRDA’s TA Score: 5 bullish, 4 bearish.
  • TRVI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both TRDA and TRVI are a good buy in the short-term.

Price Growth

TRDA (@Biotechnology) experienced а +5.70% price change this week, while TRVI (@Biotechnology) price change was +8.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.75%. For the same industry, the average monthly price growth was -3.30%, and the average quarterly price growth was +64.67%.

Reported Earning Dates

TRDA is expected to report earnings on Aug 07, 2024.

TRVI is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+3.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for TRDA with price predictions.
OPEN
A.I.dvisor published
a Summary for TRVI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TRDA($455M) has a higher market cap than TRVI($207M). TRVI YTD gains are higher at: 125.373 vs. TRDA (-12.790).
TRDATRVITRDA / TRVI
Capitalization455M207M220%
EBITDAN/AN/A-
Gain YTD-12.790125.373-10%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
TRDATRVI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Ad is loading...
TRDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRVIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUSBX32.750.42
+1.30%
MFS Blended Research Core Equity B
MKDCX25.040.25
+1.01%
BlackRock Emerging Mkts K
CPVCX24.540.23
+0.95%
abrdn International Small Cp C
CMJAX38.210.28
+0.74%
Calvert US Mid Cap Core Rspnb Idx A
CGECX8.120.06
+0.74%
Calvert Global Real Estate C

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with TRVI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then TRVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-2.95%
TRVI - TRDA
35%
Loosely correlated
+0.33%
ARDX - TRDA
34%
Loosely correlated
+28.42%
OVID - TRDA
33%
Loosely correlated
-0.33%
FOLD - TRDA
32%
Poorly correlated
-0.29%
SVRA - TRDA
32%
Poorly correlated
+0.53%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with TRDA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
+0.33%
TRDA - TRVI
36%
Loosely correlated
-2.95%
TERN - TRVI
34%
Loosely correlated
+2.84%
ATNM - TRVI
34%
Loosely correlated
+2.40%
IBRX - TRVI
30%
Poorly correlated
+2.01%
SGMO - TRVI
29%
Poorly correlated
+6.48%
More